1639.60
0.21%
Ashika Research
The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the sale of up to 28,875,000 Equity Shares by the Selling Shareholders. Further, Company expects that listing of the Equity Shares will enhance their visibility and brand image and provide liquidity to the shareholders. The Company will not receive any...
Eris Lifesciences Ltd. is trading above its 200 day SMA of 1502.5
More from Eris Lifesciences Ltd.
Recommended